0001209191-19-007244.txt : 20190205 0001209191-19-007244.hdr.sgml : 20190205 20190205135935 ACCESSION NUMBER: 0001209191-19-007244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PALMIN HARRY S CENTRAL INDEX KEY: 0001533139 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 19567300 MAIL ADDRESS: STREET 1: C/O NOVELOS THERAPUETICS, INC. STREET 2: ONE GATEWAY CENTER,SUITE 504 CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-01 0 0001069308 Acer Therapeutics Inc. ACER 0001533139 PALMIN HARRY S C/O ACER THERAPEUTICS INC. ONE GATEWAY CTR. STE 351 NEWTON MA 02458 0 1 0 0 Chief Opp. and Financial Offr Employee Stock Option (right to buy) 24.46 2019-02-01 4 A 0 27000 0.00 A 2029-02-01 Common Stock 27000 27000 D The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 1, 2020, and 1/16th of the shares vest each quarter thereafter for the remaining three years. /s/ Harry Palmin, Chief Operating and Financial Officer 2019-02-05